Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 AUD | 0.00% | +1.49% | +65.85% |
May. 01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
Apr. 22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+65.85% | 124M | |
+63.00% | 62.59B | |
-2.04% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.18% | 26.21B | |
-21.88% | 19.09B | |
+3.53% | 13.08B | |
+25.49% | 12.26B | |
+27.30% | 12.05B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Investigational New Drug Approval for Kidney Disease Medication in China; Shares Rally 11%